Sputnik Technopolis

Sputnik Technopolis is a Russian pharmaceutical manufacturing company established to facilitate the large-scale production of biotechnological products, most notably the Sputnik V COVID-19 vaccine. Located in the Technopolis Moscow Special Economic Zone, the company operates a state-of-the-art facility equipped with high-capacity bioreactors and automated bottling lines. It was founded as a strategic partnership between the R-Pharm group and the Russian Direct Investment Fund (RDIF). The site represents one of the most significant investments in Russian biotech infrastructure, focusing on viral vector vaccines and recombinant proteins. Sputnik Technopolis plays a critical role in the domestic and international supply chain for pandemic response and advanced biologic therapies.